Mercer Global Advisors »

Actuate Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.3k 3.5k 1.53
2025-03-31 $111k 16k 6.77
2024-12-31 $130k 16k 7.96